GSK Leaving Pennsylvania Emergen-C Plant, Adding Voltaren To US OTC Line

 
• By Malcolm Spicer
GSK Carlisle
GSK is phasing out production at its Carlisle, PA, production facility by mid-2021 and will full exit the site by the end of that year.

More from Rx-to-OTC Switch

More from Health